Journal article
Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis
Abstract
IMPORTANCE: The association between incretin-based drugs, such as dipeptidyl peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) agonists, and acute pancreatitis is controversial.
OBJECTIVE: To determine whether the use of incretin-based drugs, compared with the use of 2 or more other oral antidiabetic drugs, is associated with an increased risk of acute pancreatitis.
Authors
Azoulay L; Filion KB; Platt RW; Dahl M; Dormuth CR; Clemens KK; Durand M; Hu N; Juurlink DN; Paterson JM
Journal
JAMA Internal Medicine, Vol. 176, No. 10, pp. 1464–1473
Publisher
American Medical Association (AMA)
Publication Date
October 1, 2016
DOI
10.1001/jamainternmed.2016.1522
ISSN
2168-6106